Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00628277 · ClinicalTrials.gov registry record · Phase 3

Methods of Weight Loss in Overweight Coronary Patients

A Phase 3 study, sponsored by University of Vermont.

Completed
Registry status
Phase 3
Development phase
74
Enrollment target

NCT00628277: Completed Phase 3 study, sponsored by University of Vermont.

NCT00628277 is a Phase 3 study that has completed, run by University of Vermont. The registered enrollment target is 74 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00628277, a Phase 3 study, has completed, sponsored by University of Vermont.

COMPLETED
Registry status
Phase 3
Development phase
74 participants
Enrollment target

Study Summary

We hypothesize that a combination of high-caloric expenditure exercise and behavioral weight loss counseling would lead to a greater loss of fat mass and a greater improvement in cardiometabolic risk factors that standard (lower caloric expenditure) cardiac rehabilitation exercise plus counseling.

Interventions

  • BEHAVIORAL high caloric expenditure exercise
  • BEHAVIORAL low caloric expenditure exercise plus dietary counseling

Trial Details

FieldValue
Enrollment Target 74 participants
Start Date 2002-10
Est. Completion 2007-07
Phase Phase 3
University of Vermont

162 total trials

What the finished NCT00628277 record still lists

NCT00628277 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 74 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (90% lower).

The record links to 0 conditions, and to 2 interventions - of which high caloric expenditure exercise is the first listed.

NCT00628277 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00628277 about?

NCT00628277 is a clinical study titled "Methods of Weight Loss in Overweight Coronary Patients". We hypothesize that a combination of high-caloric expenditure exercise and behavioral weight loss counseling would lead to a greater loss of fat mass and a greater improvement in cardiometabolic risk factors that standard (lower caloric expenditure) cardiac rehabilitation exercise plus counseling.

What is the current status of trial NCT00628277?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 74 participants. The study started on 2002-10. Estimated completion is 2007-07.

What interventions are being tested in trial NCT00628277?

The interventions under investigation include: high caloric expenditure exercise (BEHAVIORAL), low caloric expenditure exercise plus dietary counseling (BEHAVIORAL).

Who is sponsoring clinical trial NCT00628277?

This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00628277's enrollment target sits among peer trials

74 1780th of 2000 higher than 221 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03422731 · 74 participants · Early Phase 1

    Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy

  • NCT03804853 · 74 participants · NA

    Rehabilitation Following Reverse Total Shoulder Arthroplasty

  • NCT04065776 · 74 participants · NA

    Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma

  • NCT04771156 · 74 participants · Phase 4

    Ketorolac in Palatoplasty

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00628277, the US trial registry maintained by the National Library of Medicine. NCT00628277 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.